Company: TVRD
Filing Date: 2025-02-14
Form Type: S-4/A
Source: 0001104659-25-013053
Chunk: 1089

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: S-4/A
Chunk 1089
---
A-73</div>

TABLE OF CONTENTS

#### IN WITNESS WHEREOF,
the Parties have caused this Agreement to be executed as of the date first above written.

#### TVARDI THERAPEUTICS, INC.
By:

/s/ Imran Alibhai, Ph.D.

Name:

Imran Alibhai, Ph.D.

Title:

Chief Executive Officer

<div align='center'>A-74</div>

TABLE OF CONTENTS

### EXHIBIT A

### CERTAIN DEFINITIONS
For purposes of this Agreement (including this Exhibit A):

“

#### Acquisition Inquiry
” means, with respect to a Party, an inquiry, indication of interest or request for information (other than an inquiry, indication of interest or request for information made or submitted by the Company or any of its Affiliates, on the one hand, or Parent or any of its Affiliates, on the other hand, to the other Party) that could reasonably be expected to lead to an Acquisition Proposal; provided, however , that the term “

#### Acquisition Inquiry
” shall not include the Merger or the other Contemplated Transactions or any transactions related to the Asset Dispositions.

“

#### Acquisition Proposal
” means, with respect to a Party, any offer or proposal, whether written or oral (other than an offer or proposal made or submitted by or on behalf of the Company or any of its Affiliates, on the one hand, or by or on behalf of Parent or any of its Affiliates, on the other hand, to the other Party) contemplating or otherwise relating to any Acquisition Transaction with such Party, other than the Asset Dispositions.

“

#### Acquisition Transaction
” means any transaction or series of related transactions (other than the Asset Dispositions) involving:

any merger, consolidation, amalgamation, share exchange, business combination, issuance of securities, acquisition of securities, reorganization, recapitalization, tender offer, exchange offer or other similar transaction: (i) in which a Party is a constituent entity; (ii) in which a Person or “group” (as defined in the Exchange Act) of Persons directly or indirectly acquires beneficial or record ownership of securities representing more than 20% of the outstanding securities of any class of voting securities of a Party or any of its Subsidiaries; or (iii) in which a Party or any of its Subsidiaries issues securities representing more than 20% of the outstanding securities of any class of voting securities of such Party